Akèy › Kansè (tout kalite) › Missouri › Springfield
Etid klinik pou Kansè (tout kalite) nan Springfield, MO
10 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Springfield (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Hulston Cancer Center /ID# 232226, Springfield
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Oncology Hematology Associates, Springfield
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Ap rekriteEtid obsèvasyon
- Oncology Hematology Associates, Springfield
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Mercy Hospital Springfield, Springfield
- CoxHealth South Hospital, Springfield
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Ap rekriteEtid obsèvasyon
- Mercy Hospital - SPG, Springfield
Galleri® in the Medicare Population.
Ap rekriteVolontè an sante akeyi
- Mercy Health - Springfield, Springfield
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Ap rekriteEtid obsèvasyon
- Oncology Hematology Associates, Springfield
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
- Oncology Hematology Associates, Springfield
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Ap rekriteEtid obsèvasyon
- Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center, Springfield
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- Cox South Hospital, Springfield
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan Springfield
- Kansè kolorektal11 etid
- Kansè Poumon ki pa ti selil10 etid
- Kansè nan tete10 etid
- Sipwa7 etid
- Obèsite7 etid
- Kansè Metastatik6 etid
- Melanom6 etid
- Kansè poumon6 etid
- Kansè ovè5 etid
- Kansè kolon5 etid
- Kansè pwostat4 etid
- Kansè vejik4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.